These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24731535)

  • 1. Multidisciplinary diabetes care with and without bariatric surgery in overweight people: a randomised controlled trial.
    Wentworth JM; Playfair J; Laurie C; Ritchie ME; Brown WA; Burton P; Shaw JE; O'Brien PE
    Lancet Diabetes Endocrinol; 2014 Jul; 2(7):545-52. PubMed ID: 24731535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.
    Mingrone G; Panunzi S; De Gaetano A; Guidone C; Iaconelli A; Nanni G; Castagneto M; Bornstein S; Rubino F
    Lancet; 2015 Sep; 386(9997):964-73. PubMed ID: 26369473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term impact of weight loss for people with overweight but not obesity, and with type 2 diabetes: 10-year outcomes of a randomized trial of gastric band surgery.
    Qi QYD; Playfair J; Brown WA; Burton P; O'Brien PE; Wentworth JM
    Diabetes Obes Metab; 2023 Jun; 25(6):1464-1472. PubMed ID: 36700392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes Outcomes More than a Decade Following Sustained Weight Loss After Laparoscopic Adjustable Gastric Band Surgery.
    Wentworth JM; Cheng C; Laurie C; Skinner S; Burton PR; Brown WA; O'Brien PE
    Obes Surg; 2018 Apr; 28(4):982-989. PubMed ID: 28975466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of early weight loss on type 2 diabetes mellitus after 2 years of gastric banding.
    Edelman S; Bhoyrul S; Billy H; Cornell C; Okerson T
    Postgrad Med; 2012 Nov; 124(6):73-81. PubMed ID: 23322140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric banding for the treatment of type 2 diabetes mellitus in morbidly obese.
    Brancatisano A; Wahlroos S; Matthews S; Brancatisano R
    Surg Obes Relat Dis; 2008; 4(3):423-9. PubMed ID: 18226973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.
    Dixon JB; O'Brien PE; Playfair J; Chapman L; Schachter LM; Skinner S; Proietto J; Bailey M; Anderson M
    JAMA; 2008 Jan; 299(3):316-23. PubMed ID: 18212316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjustable Gastric Band Surgery or Medical Management in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    Ding SA; Simonson DC; Wewalka M; Halperin F; Foster K; Goebel-Fabbri A; Hamdy O; Clancy K; Lautz D; Vernon A; Goldfine AB
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2546-56. PubMed ID: 25909333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications.
    Sjöström L; Peltonen M; Jacobson P; Ahlin S; Andersson-Assarsson J; Anveden Å; Bouchard C; Carlsson B; Karason K; Lönroth H; Näslund I; Sjöström E; Taube M; Wedel H; Svensson PA; Sjöholm K; Carlsson LM
    JAMA; 2014 Jun; 311(22):2297-304. PubMed ID: 24915261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
    Ritsinger V; Malmberg K; Mårtensson A; Rydén L; Wedel H; Norhammar A
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):627-33. PubMed ID: 24831989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study.
    Carlsson LMS; Sjöholm K; Karlsson C; Jacobson P; Andersson-Assarsson JC; Svensson PA; Larsson I; Hjorth S; Neovius M; Taube M; Carlsson B; Peltonen M
    Lancet Diabetes Endocrinol; 2017 Apr; 5(4):271-279. PubMed ID: 28237791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial.
    Taheri S; Zaghloul H; Chagoury O; Elhadad S; Ahmed SH; El Khatib N; Amona RA; El Nahas K; Suleiman N; Alnaama A; Al-Hamaq A; Charlson M; Wells MT; Al-Abdulla S; Abou-Samra AB
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):477-489. PubMed ID: 32445735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of gastric band surgery for overweight but not obese adults with type 2 diabetes in the U.S.
    Wentworth JM; Dalziel KM; O'Brien PE; Burton P; Shaba F; Clarke PM; Laiteerapong N; Brown WA
    J Diabetes Complications; 2017 Jul; 31(7):1139-1144. PubMed ID: 28462893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial.
    Ikramuddin S; Billington CJ; Lee WJ; Bantle JP; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Jeffery RW; Chong K; Chuang LM; Sarr MG; Jensen MD; Vella A; Ahmed L; Belani K; Schone JL; Olofson AE; Bainbridge HA; Laqua PS; Wang Q; Korner J
    Lancet Diabetes Endocrinol; 2015 Jun; 3(6):413-422. PubMed ID: 25979364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial.
    Cummings DE; Arterburn DE; Westbrook EO; Kuzma JN; Stewart SD; Chan CP; Bock SN; Landers JT; Kratz M; Foster-Schubert KE; Flum DR
    Diabetologia; 2016 May; 59(5):945-53. PubMed ID: 26983924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass.
    Hamza N; Abbas MH; Darwish A; Shafeek Z; New J; Ammori BJ
    Surg Obes Relat Dis; 2011; 7(6):691-6. PubMed ID: 20688578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric Band Surgery Leads to Improved Insulin Secretion in Overweight People with Type 2 Diabetes.
    Wentworth JM; Playfair J; Laurie C; Brown WA; Burton P; Shaw JE; O'Brien PE
    Obes Surg; 2015 Dec; 25(12):2400-7. PubMed ID: 25994778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of adjustable gastric banding in a cohort of 186 super-obese patients with a BMI≥ 50 kg/m2.
    Arapis K; Chosidow D; Lehmann M; Bado A; Polanco M; Kamoun-Zana S; Pelletier AL; Kousouri M; Marmuse JP
    J Visc Surg; 2012 Apr; 149(2):e143-52. PubMed ID: 22386891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.
    Stephens DJ; Saunders JK; Belsley S; Trivedi A; Ewing DR; Iannace V; Capella RF; Wasielewski A; Moran S; Schmidt HJ; Ballantyne GH
    Surg Obes Relat Dis; 2008; 4(3):408-15. PubMed ID: 18243060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study.
    Zinman B; Harris SB; Neuman J; Gerstein HC; Retnakaran RR; Raboud J; Qi Y; Hanley AJ
    Lancet; 2010 Jul; 376(9735):103-11. PubMed ID: 20605202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.